• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Featured
  • More News ⌄
    • SatNews
    • SatMagazine
    • MilSatMagazine
  • Events ⌄
    • MilSat Symposium
    • SmallSat Symposium
    • Satellite Innovation
  • Contacts
  • SUBSCRIPTION

SmallSat News

You are here: Home / Featured / Vector Space Biosciences reveals smallsat drug repurposing platform using data from space

Vector Space Biosciences reveals smallsat drug repurposing platform using data from space

December 4, 2023 by editorial

Vector Space Biosciences, Inc., in collaboration with Oracle and NVIDIA, has a new smallsat launch platform designed for biotechnology and pharmaceutical companies.

The platform is powered by…

1) A biosciences lab

2) A CubeSat lab

3) A language modeling/AI lab that includes an ensemble of small, highly targeted, biological language modeling and large biological language modeling (LLMs), generative AI, protein sequence matching, vector databases and advanced visualizations.

This pipeline enables the development of countermeasures against diseases associated with stressors resulting from human spaceflight. Countermeasures not only protect humans in space but also double as new forms of precision medicine for all mankind.

Once a CubeSat is designed, developed, and launched, data is transmitted to ground stations, in collaboration with Microsoft Azure Space. This data is augmented with current biomedical data and preprocessed for language modeling. Feature vectors are extracted from the trained models and are used to construct real-time hidden relationship networks between genes, proteins, diseases, drug compounds and other biochemicals.

Data generated from these smallsats in space is of high-value, unique as well as powerful and can also enable new discoveries in the areas of drug discovery, development and design in addition to drug repurposing which has proven to be a vital area of discovery as shown by the recent example of Novo Nordisk’s Wegovy (semaglutide), a weight loss drug, which has been shown to help patients lose an average of 15% of their weight, also reduced incidence of heart attack, stroke or death from heart disease by 20%.

“Without understanding how to protect and repair the human body during spaceflight, we simply won’t be establishing lunar bases or going to Mars anytime soon. However, if we focus on creating solutions in this area now, we can develop and repurpose new therapeutic applications in precision medicine that benefit all mankind, today. This is the focus of Vector Space Biosciences.” — Vector Space Biosciences founder and CEO, Kasian Franks

Vector Space Biosciences trades under the cryptocurrency symbol SBIO and enables payments via its subsidiary, Vectorspace AI and its utility token, VXV. Vector Space Biosciences, Inc., (SBIO), parent company of Vectorspace AI (VXV), along with its scientific collaborators, design, develop and launch biological small satellites (CubeSats) for purpose of generating and interpreting unique datasets related to microgravity and radiation. This leads to the development of countermeasures against diseases associated to stressors connected to protecting and repairing the human body during spaceflight. This includes using a network of scientific data engineering pipelines for building targeted language models resulting in real-time datasets which power Artificial Intelligence (AI) operations in space biosciences, biotechnology and pharmaceutical development. Working with leading scientific labs in the areas of human aging, cancer, and nutrigenomics, our goal is to accelerate the process of new hypothesis generation and novel discoveries in space biosciences, including materials sciences in the area of nanotechnology and nanomedicines. Developing advanced large and small language modeling/AI technologies, our platform is capable of producing more than 100,000,000,000 different real-time datasets for the purpose of accelerating discoveries. Innovations in space biosciences result in products and services for all industries, including the financial markets, more importantly, new forms of precision medicine for all humankind. Please visit us at vectorspacebio.science for more information.

Filed Under: Featured, News

Primary Sidebar

WEEKLY NEWSLETTER

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019

© 2019–2025 SatNews

x
Sign Up Now!

Enjoy a free weekly newsletter with recent headlines from the global SmallSat industry.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.
Thanks for subscribing! You will now receive weekly SmallSat News updates.
We love our advertisers.
And you will too!

Please disable Ad Blocker to continue... We promise to keep it unobtrusive.
We promise not to spam you. You can unsubscribe at any time.
Invalid email address
Thanks for subscribing! Please check your email for further instructions.